When the doctor encourages you to buy the HPV vaccine, nowhere on the HHS Vaccine Information Sheet you are given, are you told that some of your money goes back to HHS because they own 9 patents on the vaccine.
In 2003, UPI reporter Mark Benjamin wrote an in depth piece on the conflicts of interest (COI) in vaccine safety entitled, “UPI Investigates: The vaccine conflict.” He brought to light the patents and Conflicts of interests held by the members of the US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, including Rotavirus vaccine patent holder Dr. Paul Offit, documenting the early years of Offit’s false vaccine claims claims and failure to disclose his COIs. In this article, Offit asserts that holding vaccine patents, being funded by Merck and having Merck buy and distribute his book extolling the virtues of vaccines to physicians, does not compromise his objectivity as a member of the committee that determines what is and is not sound vaccine practice:
“When asked, members of the committee told UPI their potential conflicts do not affect their judgment. “I am probably just the kind of person you are talking about,” said Paul Offit, chief of infectious diseases at the Children’s Hospital of Philadelphia, who was a committee member until last month. At the same time, he shared a patent for another rotavirus vaccine. Merck has funded Offit’s research for 13 years. “I am a co-holder of a patent for a (rotavirus) vaccine. If this vaccine were to become a routinely recommended vaccine, I would make money off of that,” Offit said. “When I review safety data, am I biased? That answer is really easy: absolutely not.”
“Is there an unholy alliance between the people who make recommendations about vaccines and the vaccine manufacturers? The answer is no.’”
Merck bought and delivers copies of Offit’s book, “What Every Parent Should Know About Vaccines,” to American doctors. The book has a list price of $14.95.
“Merck Vaccine Division is pleased to present you with a copy of the recent publication, ‘What Every Parent Should Know about Vaccines,'” says a Dear Doctor letter from Merck. “The authors designed the book to answer questions parents have about vaccines and to dispel misinformation about vaccines that sometimes appears in the public media.”
Offit said he does not know how many copies of his book Merck purchased. “I don’t have any control over that,” he said.”
However, the specifics and number of CDC vaccine patents are not reviewed in Mr. Benjamin’s article.
In 2010 Mark Blaxill, a vaccine safety advocate and Intellectual Property expert who has been employed by billion dollar corporations to manage their patents did a follow up investigation into vaccine patents owned by HHS. He discovered that HHS, through NIH, owns patents on all HPV vaccines, and receives a percentage of the profits for each dose of Gardasil and Cervarix administered anywhere in the world. He published the stunning revelation in a detailed three part expose entitled, “A License to Kill? Part 1: How A Public-Private Partnership Made the Government Merck’s Gardasil Partner.”
A 2017 review of US patents with the CDC listed as an assignee found more than 50, making the agency that recommends vaccines to the public financial partners in the products they are recommending currently, but also making the companies which they oversee, their potential customers for their patented products.. You can see the current search results here.
CDC holds patents applicable to vaccines for Flu, Rotavirus, Hepatitis A, HIV, Anthrax, Rabies, Dengue fever, West Nile virus, Group A Strep, Pneumococcal disease, Meningococcal disease, RSV, Gastroenteritis, Japanese encephalitis, SARS, Rift Valley Fever, and chlamydophila pneumoniae.
There is a CDC patent for “Nucleic acid vaccines for prevention of flavivirus infection,” which has applications in vaccines for Zika, West Nile virus, Dengue fever, tick-borne encephalitis virus, yellow fever, Palm Creek virus, and Parramatta River virus.
CDC also has several patents for administering various ”shots” via aerosol delivery systems for vaccines.
There’s a CDC patent on a process for vaccine quality control by “quantifying proteins in a complex preparation of uni- or multivalent commercial or research vaccine preparations.”
There’s a CDC patent on a method “for producing a model for evaluating the antiretroviral effects of drugs and vaccines.”
CDC has a patent for companies who want to test their respiratory system applicable vaccine on an artificial lung system.
If a vaccine maker is concerned that their vaccine might contain a human rhinovirus, CDC has a patent on a process for determining if such contamination exists.
CDC has a patent on an assay to assist vaccine makers in finding antigen-specific antibodies in a biological sample.
CDC holds a patent that provides vaccine makers with a method of “reducing the replicative fitness of a pathogen by deoptimizing codons.” Asserting that, “pathogens with deoptimized codons can be used to increase the phenotypic stability of attenuated vaccines.”
The agency also holds a patent on adjuvants for a vaccine used on premature infants and young babies.
There is a CDC patent to cover a vaccine for an infection induced by a tape worm found in pork.
Does this seem like a public health agency making “independent” vaccine recommendations, or a private company with an impressive portfolio to which one might look for investment opportunities?
The CDC is reputed to be an independent government agency making vaccine recommendations to the public, only for the public good. They are the agency charged with vaccine safety oversight, via their Immunization Safety Office.
Here is how the office describes its charge:
“CDC’s Immunization Safety Office plays a vital role in ensuring our nation’s vaccine safety. Sound immunization policies affecting children and adults in the U.S. depend on continuous monitoring of the safety and effectiveness of vaccines. CDC uses many strategies to assess vaccine safety, to identify health problems possibly related to vaccines, and to conduct studies that help determine whether a health problem is caused by a specific vaccine. CDC also works with other federal government agencies and other stakeholders to determine the appropriate public health response to vaccine safety concerns and to communicate the benefits and risks of vaccines. The Immunization Safety Office regularly reports on vaccine safety monitoring findings and any concerns to CDC’s Advisory Committee on Immunization Practices (ACIP). This advisory group develops the recommended vaccine schedule for children and adults in the U.S. ACIP considers the safety and effectiveness of vaccines before making recommendations to the vaccine schedule or changing recommendations for vaccine use.”
Note that they proudly state that they report to the ACIP – the same committee on which Paul Offit infamously served, as if this reporting somehow adds legitimacy to their vaccine safety work. The same committee that Congress has excoriated for their long history of conflicts of interests.
Nowhere on the CDC’s web site is there found the disclosure that the agency is a profit partner with the vaccine makers for over whom it is supposed to be providing safety oversight.
This brief look at current patents held by the CDC deserves an in-depth review to determine exactly what current financial relationships with vaccine makers now exist and what the current impact those revenue streams are likely having on vaccine safety positions. Furthermore, one must closely look at the financial relationships between the CDC and vaccine makers it is currently courting, to include the potential exploitation of new patents for financial gain.
The US Centers for Disease Control and Prevention hold oversight of the vaccine industry, while failing to disclose that it is a part of the vaccine industry.
The vaccine business is currently more than a $30 billion per year industry in which organizations like the World Health Organization have urged increased investment, projecting that it will become a $100 billion per year industry by 2025. Thus, it is advantageous to the CDC and their business partners for the public to not only accept the 69 doses of recommended childhood vaccines, but to begin to adhere to the additional 100 plus doses of vaccines recommended by the adult schedule, and to be ready to inject their families with the additional 271 vaccines in the development pipeline.
That profit boom can’t happen if the corruption in the industry, and the vast, unassessed damage that it has done to the health of children (and now adults) is laid open for all to finally see. It is likely $30 billion per year industry will become a sub $10 billion per year industry, with a cap on how much it can make. Because there is a cap on how much the human body can process.
Further, as the US Government commandeered ownership of the on the WI-38 aborted fetal cell line from Leonard Hayflick, the developer of the product, financial losses would follow if the vaccines made with these cell lines like MMR and Chickenpox vaccine were rejected by the Christian community. This is a disincentive from not only performing the safety testing of the use of aborted fetal cell lines in vaccines that the public has asked for, but from even disclosing the use of these lines widely to the public.
The CDC is a deceitful entity that has betrayed families, and does not deserve the public trust that it enjoys.
“Do not be deceived: God is not mocked, for whatever one sows, that will he also reap. For the one who sows to his own flesh will from the flesh reap corruption, but the one who sows to the Spirit will from the Spirit reap eternal life. Galatians 6:7-8